Charles Quesenberry to Thiazolidinediones
This is a "connection" page, showing publications Charles Quesenberry has written about Thiazolidinediones.
Connection Strength
0.558
-
Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes. JAMA. 2015 Jul 21; 314(3):265-77.
Score: 0.125
-
Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer. Pharmacoepidemiol Drug Saf. 2014 Jun; 23(6):636-45.
Score: 0.115
-
Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care. 2011 Apr; 34(4):916-22.
Score: 0.093
-
Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care. 2011 Apr; 34(4):923-9.
Score: 0.093
-
Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus. Gastroenterology. 2008 Dec; 135(6):1914-23, 1923.e1.
Score: 0.078
-
Glycemic response to newly initiated diabetes therapies. Am J Manag Care. 2007 Nov; 13(11):598-606.
Score: 0.037
-
Medical therapy for diabetes is associated with increased use of lower endoscopy. Pharmacoepidemiol Drug Saf. 2007 Nov; 16(11):1195-202.
Score: 0.018